Randomized Phase II Study of Gemcitabine Plus Z-360 in Metastatic Pancreatic Adenocarcinoma Compared With Gemcitabine Plus Placebo ( ZIPANG Study )
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Z 360 (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms ZIPANG
- Sponsors Zeria
- 29 Jun 2017 Status changed from active, no longer recruiting to completed.
- 04 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
- 22 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.